High Net Worth, Family Office IR 
Distinctive Focus, Exceptional Execution

Our programs are designed for small cap life sciences issuers who seek a closer relationship between their intrinsic and public market values.

CLICK TO DOWNLOAD

Our approach is built on more than 25 years of working with some of the industry’s most gifted entrepreneurs as they guided the early days of companies like Celgene, Calgene, Medarex, Texas Biotechnology, Axsome, TG Therapeutics, Keryx, Fortress Biotech, Quidel, Elan, Urigen, Galapagos, Stemcell, Crucell, and many others -- all bearing witness to the value proposition of translating science and opportunity to a level of understanding, then presenting it in ways and in places that matter most to risk-tolerant investors.

In the process we gained exceptional insights into how investors view risk investments in life sciences and the message elements that are most effective in drawing their attention. Tailored programs involve a mix of outreach tools that include media, digital communications, analyst reports, industry perspectives, corporate profiles, teach-ins, and non-deal road shows.

We actively communicate with roughly 2,600 financial advisors at local, regional and national wire houses, more than 200 family offices and 10,000 medically degreed high net worth investors.

As a class, these investors are the ones that generally set share price and account for routine daily liquidity of small cap issuers. That is why we focus on them: their investment strategies enable them to build positions in small cap companies in the public market before the time when market caps or liquidity meet the criteria of most institutional investors.

We use a variety tools to accomplish our work

At A Glance

Investor-driven narrative of the company’s lead programs
MORE INFO

At A Glance

Investor-driven narrative of the company’s lead programs, anticipated outcomes, commercial and regulatory environments, and milestone events calendar.
MORE INFO

Redington Virtual

Web-based outreach to ticker-based of leading financial websites
MORE INFO

Redington Virtual

Web-based outreach to ticker-based of leading financial websites, coupled with desktop delivery of client video and text material to 16,000 financial advisors, and 10,000 high net worth medical professionals.
MORE INFO

Redington Medica

Doctor-directed desktop distributions to medically degreed professionals 
MORE INFO

Redington Medica

Doctor-directed desktop distributions to medically degreed professionals with the highest evidenced interest in small cap life science companies in our universe.
MORE INFO

Investor Contact Unit (ICU)

The ICU tracks , and reinforces client news flow with timely information
MORE INFO

Investor Contact Unit (ICU)

The ICU tracks stock ownership, trending impressions of client companies, and reinforces client news flow with timely information on commercial or regulatory activities than may influence client programs.
MORE INFO

Road Show Unit

Produces financial advisor meetings in 20 markets in the US.
MORE INFO

Road Show Unit

Participants represent a cross section of the financial community in each market, including major wires houses and regional firms.
MORE INFO

Seeking Donerail

Investor and partner-funded angel investor combining our unique understanding of life sciences investing with the growing needs of emerging private and public companies.
MORE INFO

Seeking Donerail

Investor and partner-funded angel investor combining our unique understanding of life sciences investing with the growing needs of emerging private and public companies.
MORE INFO

Media

Articles written by financial journalists appear on the platforms of multiple ticker-based content partners.
MORE INFO

Media

Articles written by financial journalists appear on the platforms of multiple ticker-based content partners.
MORE INFO

Case Histories

A sampling of case histories.
MORE INFO

Case Histories

A sampling of case histories.
MORE INFO

Ph: 212 926-1733     Email: info@redingtoninc.com